A A AText only | Accessibility | Privacy and cookies

Browse site A to Z

Search results

Go To Advanced Search

You could also try: resembling (46)

Raltitrexed Ver 1.2

Description
Chemotherapy Protocol COLORECTAL CANCER Regimen RALTITREXED Colorectal Cancer– Raltitrexed Indication Treatment of metastatic / advanced colorectal cancer where fluorouracil and / or capecitabine
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Colorectal/RaltitrexedVer12.pdf

Panitumumab (21 day) Ver 1.1

Description
Chemotherapy Protocol COLORECTAL CANCER PANITUMUMAB (21 day) This regimen may require funding and is an unlicensed dose Regimen Colorectal Cancer – Panitumumab
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Colorectal/Panitumumab21dayVer11.pdf

Fluorouracil Folinic Acid

Description
Chemotherapy Protocol COLORECTAL CANCER FLUOROURACIL and FOLINIC ACID (Modified de Gramont) Regimen • Colorectal Cancer– Fluorouracil and Folinic Acid (Modified de Gramont
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Colorectal/Fluorouracil-Folinic-Acid.pdf

ColorectalTrifluridineTipiricilVer1

Description
Chemotherapy Protocol Regimen COLORECTAL CANCER TRIFLURIDINE-TIPIRACIL  Colorectal Cancer – Trifluridine-Tipiracil Indication  Trifluridine-tipiracil is recommended as a third or subsequent
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Colorectal/ColorectalTrifluridineTipiricilVer1.pdf

Cetuximab-Fluorouracil-Folinic Acid-Oxaliplatin

Description
Chemotherapy Protocol COLORECTAL CANCER CETUXIMAB-FLUOROURACIL-FOLINIC ACID (Modified de Gramont)OXALIPLATIN Regimen • Colorectal Cancer – Cetuximab-Fluorouracil-Folinic Acid (modified de
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Colorectal/Cetuximab-Fluorouracil-FolinicAcid-Oxaliplatin.pdf

Everolimus Ver 1

Description
Chemotherapy Protocol PANCREATIC NEUROENDOCRINE CARCINOMA EVEROLIMUS This protocol may require funding Regimen PNET - Everolimus Indication The first or second line treatment
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Endocrinecancer/Everolimus-Ver-1.pdf

Temozolomide (200)

Description
Chemotherapy Protocol Central Nervous System TEMOZOLOMIDE (200) Regimen • CNS – Temozolomide (200) Indication • Recurrent or progressive malignant glioblastoma multiforme in patients not
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CNS/Temozolomide-200.pdf

Free Training and Development Event: ThinkWrite Quality Papers

Description
Auto Generated Title The NIHR Biomedical Research Centre (BRC) Southampton in collaboration with the Southampton Academy of Research (SoAR) are proud
Url
/ClinicalResearchinSouthampton/For-researchers/Education-and-training/Events/Free-Training-and-Development-Event-ThinkWrite-Quality-Papers.aspx

Passing patient information to the police

Description
In what circumstances should medical professionals pass confidential information to the police?
Url
/HealthProfessionals/Clinical-law-updates/Passing-patient-information-to-the-police.aspx

Communicating risk: words or numbers?

Description
Is it better to communicate risks to patients with words or statistics?
Url
/HealthProfessionals/Clinical-law-updates/Communicating-risk-words-or-numbers.aspx
321 to 330 of 757
Previous … 31 32 33 34 35 … Next